• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Nektar Therapeutics

Nektar Therapeutics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Nektar Therapeutics' stock jumps after positive results of its pain treatment drug

    Nektar Therapeutics' stock jumps after positive results of its pain treatment drug

  2. Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

    Ovarian Cancer Treatment Landscape & Competitive Analysis, 2017 - Research and Markets

  3. PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy

    PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy

  4. Biotech Fans Could Have a Hangover

    This corner of the health-care market could be poised to fall further than others.

  5. Biotech Fans Could Have a Hangover

    This corner of the health-care market could be poised to fall further than others.

  6. Five Consensus Views that Could Prove Wrong in 2015

    Options on this firm's blockbuster cost a little but pay off big.

  7. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

©2017 Morningstar Advisor. All right reserved.